{"name":"ConSynance Therapeutics","slug":"consynance-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNSzNscWQ5YlhFN29Ub3F0VFNTNXI1dFVlLV9ja0g1d2Y4aDFVaEUxVU04emZDVUNxSFQzdUNjSGk5RVJPMm11N0tQb0c1dHc0TUMzaU1RYkdqVUtsOERkYTJFeHF3QW1xZzNQYU00Tlp2U0tHMEFqb0xZMEl0RFU2OTRUQ1piWmo2U0hFR2FDdmt1SFBBVlFiY3RQalpwN3Z6WHc?oc=5","date":"2026-04-06","type":"pipeline","source":"openPR.com","summary":"Prader-Willi Syndrome Market Size in the 7MM was ~USD 600 million - openPR.com","headline":"Prader-Willi Syndrome Market Size in the 7MM was ~USD 600 million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPQ3RLVTFEWTVXMVZyNl9UZk8zRHhwN2dEVzVWQ0dSdzlGU0pWSmJLVnRHYkRJVzhOVmJ2end1b19pd3pDRm5tLThMb0h2Y2Y3UUloYWduMjJ4RnhneWNEYXdiLVlJNWpvSlg0REVkWUN1cWttN0VfYnhLc1RUWnQzNnhIdVdfaXR4bWVfME1VT1pRaFhTUklmUHZrRUV1YWJjSV9XRWtzaXhkQmNMMnRoX250aw?oc=5","date":"2024-07-25","type":"regulatory","source":"Pharmaceutical Technology","summary":"ConSynance wins FDA designation for Prader-Willi syndrome therapy - Pharmaceutical Technology","headline":"ConSynance wins FDA designation for Prader-Willi syndrome therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AJBVV95cUxQQVk1czJpSWhFMHhqREF4YXBRVjJUaTUzTVZ0RndpV2V2OUpyUnJTSV9pelRPUFJQaW5YMnd1ekRvb1phRW96M2F2ZXdVZnNFem5yRF9uWHJpX3N2SnhER2MwU3l3TENuZzNMZGFfRmdtTnBtbEV3cWJOQU5DVDF3QW1KV3VrUzNfcm1FS3poY2FfN3BubnlhY2hnVkNDeFpHMVRhZVljeHluSUxpazVXeW5vUUlZcGU3RkJPZTNidmFXY2ZNS0JHSWVXVDdSQzdteHE1ZnJhMXE2Ni00aUgxdzdLdFJzb3lkUnJNVnFoTXBULWpYMTl0TzQtRE5VUE9kWU9Xbl82c2x2bXVqNmpTQlk0bndjaENxQ0d3TVhVR2NVYWd2U290REtxR0t6dXNfUHN0bnRJRGFTR2YyQUJhMmlMRUxpNzVSSFA1WW5qWlBGR2I2eldfTVhJd2dyalVHdlNITmU1Xzl1Y3AySEc5R2xtc0k?oc=5","date":"2023-11-13","type":"pipeline","source":"PR Newswire","summary":"Prader-Willi Syndrome Market is Likely to Increase at a Steady Growth Rate by 2032, Estimates DelveInsight | Leading Companies - Neuren, Aardvark, Jazz, Gedeon Richter, Harmony Biosciences, Soleno The","headline":"Prader-Willi Syndrome Market is Likely to Increase at a Steady Growth Rate by 2032, Estimates DelveInsight | Leading Com","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPRFIxM25ZMjdobk5CVUhKNjdkdWVpOTU4WUE4dEpmRlAxdGo2bWRLTHF6d3NYWkM0bmR2bHVkZmpaVVpkUEp3NXRlczJwSmRIWlVuWmZ6RTRkMXRSaUotbG5hcHJmUEFmaFJIUGFNOU1YZjY0OFVITGx5TnBxQ0l0NmJneWlzZ1dDWWdiZTRRaUs0a255eS1yeUVUSW5XaUdN?oc=5","date":"2023-07-24","type":"pipeline","source":"openPR.com","summary":"Prader-Willi Syndrome Market is Expected to Expand at a Healthy - openPR.com","headline":"Prader-Willi Syndrome Market is Expected to Expand at a Healthy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQS2VOOFc5aVktNDRSQmdDNG1rYkVMT1MxWTlBS0Jkcl9nTjAzOXVna3NIUXlzZkRQaGJBdWJxc0V1NjVFUGNyZWRKUl9tOURYVmV4UGhvZVlmd1oxeEt4WkY5dGdscXFsRm9xUGgzcVZ5c3kyTnk2dXNPeVhoUnQ3aXRjTEF6NHl6a0ZxU0dCWFBuaXdwcVk4?oc=5","date":"2023-05-31","type":"trial","source":"Clinical Trials Arena","summary":"Positive Phase I results for Prader-Willi Syndrome drug - Clinical Trials Arena","headline":"Positive Phase I results for Prader-Willi Syndrome drug","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOMDgtczRNMnRpRXpjXzc3amJFdFFpS3lCREYyMl8xRVVoNW1ZUml6ZnktTVpnWmtobmtSUmRHM25Gd1hDWk5IUzdJM1ExMU1aSlZzWFpQajBoaGZjZDJxb19mcF9xTm5xWTQtV3RsN1JndkdHZTA2UVJ4SThiVGtNZWRnMlhwZXd0Z1piZnIwbVZOd2h5cUtJRXhvMW8?oc=5","date":"2022-06-18","type":"trial","source":"globaldata.com","summary":"Prader-Willi Syndrome (PWS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - globaldata.com","headline":"Prader-Willi Syndrome (PWS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwJBVV95cUxPMjFmNFE3Q3c5VDl3QjJXTl9SX3NpU1Flb0M3TFdMSUgteFA0LUxSTWlaLThIZWJyTW9paTYtU1RFT1N0ZU8zblFaVjFqSzVaSDJsQS03clJoclRnOXJncTAzMERlZGxBRG91WWIyRWVyTGlKelQ5U29WeU9oRjlsTEtNVXh3dF9NbUY1TVRaR29ZdlZxTFgxX2lDNGVoeldvM0VJalNoM3BnQ3JkSncybG44d0dMLUtKM3Y2QUxQWDhkSmRPMU1ZTFlodlU4YXhmamVzN3EzS093a21RQnZQTVlndnpyTHV0bVBhV1VzNmFEbWx0dGdvTlIzT1ZMOXdBSVhXeWV0ODlHRDR4d1FPZk5sNFFaQ2pXX0d2QllJZE5TUkdrWjBB?oc=5","date":"2021-08-09","type":"deal","source":"PR Newswire","summary":"Harmony Biosciences Acquires Asset With Novel Mechanism Of Action For The Potential Treatment Of Narcolepsy And Other Rare Neurological Diseases - PR Newswire","headline":"Harmony Biosciences Acquires Asset With Novel Mechanism Of Action For The Potential Treatment Of Narcolepsy And Other Ra","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}